Novel Antifungal Discovery: An Introduction to the Pipeline
How new antifungal agents are discovered and developed, from novel targets and natural products to trials and global access.
An overview of what you will study and build.
Novel Antifungal Discovery: An Introduction to the Pipeline explains how new antifungal agents are found and brought towards patients, and why so few have reached the market. Students explore the antifungal development gap, new molecular targets and mechanisms, and the roles of natural products and drug repurposing. The course then covers preclinical models, the design of clinical trials and regulatory pathways for anti-infectives, and closes with questions of access, cost and global equity, which shape whether new drugs reach the people who need them.
Several first-in-class antifungals are now in development, creating demand for professionals who understand the pipeline from discovery to access. This course suits pharmaceutical, research and regulatory professionals. Tutors are drug development scientists and regulatory specialists. For the final project, students produce a pipeline profile of one investigational antifungal agent or class, summarising its target, development stage, evidence base, regulatory considerations and access challenges, using publicly available information.
6 modules, one growing line of knowledge.
Hover or tap a module to follow the path from the first session to the final project. Open a module to see the topics it covers.
- Why few antifungals reach the market
- Scientific obstacles
- Economic incentives
- Cell wall and membrane targets
- Novel enzymes and pathways
- First-in-class mechanisms
- Screening natural product libraries
- Repurposing approved drugs
- Combination strategies
- In vitro models
- Animal infection models
- Pharmacokinetics and safety studies
- Trial design for invasive fungal disease
- Regulatory incentives and pathways
- Endpoints and comparators
- Pricing and reimbursement
- Access in low-resource settings
- Global initiatives for equity
Novel Antifungal Discovery: An Introduction to the Pipeline
By the end you will be able to:
- Explain why antifungal drug development lags behind need.
- Describe novel targets and mechanisms in the antifungal pipeline.
- Compare discovery approaches including natural products and repurposing.
- Outline preclinical and clinical development steps for anti-infectives.
- Analyse access and equity challenges for new antifungal agents.
Where this programme sits in the school.
Where this programme can take you.
Roles and uses that build on what you learn here. Outcomes depend on your experience and local market.
- Research scientist in antifungal drug discovery
- Regulatory affairs associate for anti-infectives
- Clinical trial assistant or coordinator
- Market access and health economics analyst
- Business development analyst in biotechnology
Requirements, assessment and certificate.
Admission requirements
A life-science or pharmaceutical background is recommended; no prior mycology knowledge is required.
How you are assessed
Students are assessed through participation in live sessions and exercises analysing pipeline data. The final profile is reviewed by the professor.
Final project
A pipeline profile of one investigational antifungal agent or class based on publicly available information.
Certificate
Course Certificate
On completing the programme and its project, Fungaris issues a Course Certificate. Accreditations are assessed according to the training completed and the local regulations of each country.
How the programme grows, phase by phase.
- The antifungal development gap
- New targets and mechanisms
- Natural products and drug repurposing
- Preclinical models
- Clinical trials and regulatory pathways
- Access, cost and global equity
Related searches
Questions about this programme
Do I need experience to study Novel Antifungal Discovery: An Introduction to the Pipeline?
A life-science or pharmaceutical background is recommended; no prior mycology knowledge is required.
How is Novel Antifungal Discovery: An Introduction to the Pipeline taught?
Live online, in 6 modules with a working professional, a small group and a final project.
How am I assessed?
Students are assessed through participation in live sessions and exercises analysing pipeline data. The final profile is reviewed by the professor.
What is the final project?
A pipeline profile of one investigational antifungal agent or class based on publicly available information.
What certificate do I get?
On completing the programme and its project, Fungaris issues a Course Certificate. Accreditations are assessed according to the training completed and the local regulations of each country.
What can I study after Novel Antifungal Discovery: An Introduction to the Pipeline?
The natural next step is Diploma in Medical Mycology Foundations.
Keep branching.
Join the next intake.
Pay in full with a 20% reduction, or reserve your place with 40% and pay the rest in monthly instalments. All prices are stated in US dollars (USD).